COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs – Reuters

COVID R&D Alliance launches trial of Amgen, UCB, Takeda drugs – Reuters

Amgen Inc, UCB SA and Takeda Pharmaceuticals Inc on Monday launched a global trial to identify whether any of three different drugs can reduce the severity of COVID-19 in hospitalized patients by moderating the immune system’s response to the disease.

Read More…

You May Also Like